Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Huang, Yangqing ^a,b   Feng, Helin ^c   Kan, Tong ^a   Huang, Bin ^a   Zhang, Minfeng ^a   Li, Yesheng ^a   Shi, Changying ^a   Wu, Mengchao ^a   Luo, Yunquan ^b   Yang, Jiamei ^a   Xu, Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Shuguang Hospital   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOGENESIS INHIBITOR; BEVACIZUMAB; CARBON TETRACHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FIBROGENESIS; IN VIVO STUDY; LIVER CELL; LIVER FIBROSIS; LIVER PROTECTION; MALE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; STELLATE CELL; TISSUE INJURY;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; CARBON TETRACHLORIDE; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; DOWN-REGULATION; HEPATIC STELLATE CELLS; HEPATOCYTES; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84883411552     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073492     Document Type: Article

References (36)

1. Wynn TA, (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117: 524-529.
2. Friedman SL, (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275: 2247-2250.
3. Carmeliet P, (2005) Angiogenesis in life, disease and medicine. Nature 438: 932-936.
4. Lee JS, Semela D, Iredale J, Shah VH, (2007) Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte? Hepatology 45: 817-825.
5. Medina J, Arroyo AG, Sanchez-Madrid F, Moreno-Otero R, (2004) Angiogenesis in chronic inflammatory liver disease. Hepatology 39: 1185-1195.
6. Tugues S, Fernandez-Varo G, Munoz-Luque J, Ros J, Arroyo V, et al. (2007) Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats. Hepatology 46: 1919-1926.
7. Taura K, De Minicis S, Seki E, Hatano E, Iwaisako K, et al. (2008) Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis. Gastroenterology 135: 1729-1738.
8. Rosmorduc O, Wendum D, Corpechot C, Galy B, Sebbagh N, et al. (1999) Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol 155: 1065-1073.
9. Maria De Souza M, Tolentino M Jr, Assis BC, Cristina De Oliveira Gonzalez A, Maria Correia Silva T, et al. (2006) Pathogenesis of septal fibrosis of the liver. (An experimental study with a new model.). Pathol Res Pract 202: 883-889.
10. Bataller R, Brenner DA, (2001) Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 21: 437-451.
11. Kinoshita K, Iimuro Y, Fujimoto J, Inagaki Y, Namikawa K, et al. (2007) Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis. Gut 56: 396-404.
12. Bataller R, Brenner DA, (2005) Liver fibrosis. J Clin Invest 115: 209-218.
13. Chen SW, Chen YX, Zhang XR, Qian H, Chen WZ, et al. (2008) Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats. Gene Ther 15: 1424-1435.
14. Ishikawa K, Mochida S, Mashiba S, Inao M, Matsui A, et al. (1999) Expressions of vascular endothelial growth factor in nonparenchymal as well as parenchymal cells in rat liver after necrosis. Biochem Biophys Res Commun 254: 587-593.
15. Ankoma-Sey V, Wang Y, Dai Z, (2000) Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells. Hepatology 31: 141-148.
16. Aleffi S, Petrai I, Bertolani C, Parola M, Colombatto S, et al. (2005) Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 42: 1339-1348.
17. Novo E, Cannito S, Zamara E, Valfre di Bonzo L, Caligiuri A, et al. (2007) Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. Am J Pathol 170: 1942-1953.
18. Ferrara N, Hillan KJ, Gerber HP, Novotny W, (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3: 391-400.
19. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342.
20. Valachis A, Polyzos NP, Patsopoulos NA, Georgoulias V, Mavroudis D, et al. (2010) Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials. Breast Cancer Res Treat 122: 1-7.
21. Chaparro M, Sanz-Cameno P, Trapero-Marugan M, Garcia-Buey L, Moreno-Otero R, (2007) Mechanisms of angiogenesis in chronic inflammatory liver disease. Ann Hepatol 6: 208-213.
22. Coulon S, Heindryckx F, Geerts A, Van Steenkiste C, Colle I, et al. (2011) Angiogenesis in chronic liver disease and its complications. Liver Int 31: 146-162.
23. Lai WK, Adams DH, (2005) Angiogenesis and chronic inflammation; the potential for novel therapeutic approaches in chronic liver disease. J Hepatol 42: 7-11.
24. Fernandez M, Semela D, Bruix J, Colle I, Pinzani M, et al. (2009) Angiogenesis in liver disease. J Hepatol 50: 604-620.
25. Van Bergen T, Stalmans I (2010) The effect of bevacizumab on human Tenon fibroblasts in ocular wound healing. Invest Ophthalmol Vis Sci 51: 6903-6904; author reply 6904.
26. Thabut D, Shah V, (2010) Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J Hepatol 53: 976-980.
27. Mejias M, Garcia-Pras E, Tiani C, Miquel R, Bosch J, et al. (2009) Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology 49: 1245-1256.
28. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, et al. (2000) Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 156: 965-976.
29. Corpechot C, Barbu V, Wendum D, Kinnman N, Rey C, et al. (2002) Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 35: 1010-1021.
30. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613.
31. Taniguchi E, Sakisaka S, Matsuo K, Tanikawa K, Sata M, (2001) Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem 49: 121-130.
32. Shimizu H, Miyazaki M, Wakabayashi Y, Mitsuhashi N, Kato A, et al. (2001) Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol 34: 683-689.
33. Wang YQ, Luk JM, Ikeda K, Man K, Chu AC, et al. (2004) Regulatory role of vHL/HIF-1alpha in hypoxia-induced VEGF production in hepatic stellate cells. Biochem Biophys Res Commun 317: 358-362.
34. Issa R, Zhou X, Constandinou CM, Fallowfield J, Millward-Sadler H, et al. (2004) Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 126: 1795-1808.
35. Zhong W, Shen WF, Ning BF, Hu PF, Lin Y, et al. (2009) Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats. Hepatology 50: 1524-1536.
36. Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, et al. (2000) Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 119: 466-478.